Researchers have developed a soft artificial retina that helped blind mice respond to near-infrared light, a type of light ...

Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...

Roughly 200 million people worldwide live with age-related macular degeneration, a condition that erodes central vision and, ...

The retina, the thin layer of tissue at the back of the eye, is made up of photoreceptor cells that convert visible light ...

Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Prevent Blindness, the nation's leading patient advocacy organization dedicated to protecting and preserving eye health, has ...

When preparing for cataract surgery in patients with retinal pathologies, ophthalmologists must be sure to set reasonable ...

Retinal diseases are among the fastest growing causes of blindness, having a profound impact on patients’ independence and ...

There may be some truth to the saying "the eyes are the window to the soul." Age-related changes are reflected in the retina, ...